Porphyria cutanea tarda

Last reviewed March 21, 2026

🖨 Print for my doctor Advocacy Hub →

ORPHA:101330OMIM:176090E80.1

Who is this for?

Show terms as

13Specialists 8Treatment centers

Where are you in your journey?

ℹ

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.

Report missing data

Overview

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormal erythrocyte enzyme concentration or activityHP:0030272Elevated hepatic iron concentrationHP:0012465Decreased circulating hepcidin concentrationHP:0031876Exacerbated by tobacco useHP:0032500Addictive alcohol useHP:0030955Chronic hepatitisHP:0200123Systemic lupus erythematosusHP:0002725Hematological neoplasmHP:0004377Recurrent bacterial skin infectionsHP:0005406

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events

Nov 2026Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI

Salus University — PHASE2

TrialNOT YET RECRUITING

Mar 2026Trial of Acceptance and Mindfulness-based Exposure Therapy (AMBET) and Present Centered Therapy (PCT)

Columbia University — NA

TrialRECRUITING

Mar 2026A Novel Approach in the Evaluation of Breast Masses With Doppler US

Ahmet Yesildag

TrialRECRUITING

Nov 2025KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic Use - Comparing Procalcitonin Kinetics-guided and Absolute Procalcitonin Value-guided Antibiotic Initiation in Reducing Unnecessary Antibiotic Use in Critically Ill Patients

Semmelweis University — NA

TrialRECRUITING

Jun 2025PCT Guided Antibiotics Use in Critically Ill Adult Patients in China

China-Japan Friendship Hospital — NA

TrialNOT YET RECRUITING

Jun 2025A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants

Corxel Pharmaceuticals — PHASE2

TrialACTIVE NOT RECRUITING

Jun 2025Procalcitonin Aided Antimicrobial Therapy vs Standard of Care

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria — NA

TrialNOT YET RECRUITING

May 2025Effectiveness of a Peer Support Media Model on Obesity and Sarcopenia Awareness in At-Risk College Students

China Medical University Hospital — NA

TrialRECRUITING

Mar 2025Effects of Barley Green on Visceral Fat Area in the Human Body and Investigation Into the Associated Mechanism of Intestinal Microbiota

Peking University People's Hospital — NA

TrialRECRUITING

Mar 2025SOFA Score with Serum Procalcitonin Versus SOFA Score with Neutrophil/lymphocyte Ratio in Predicting Sepsis and Clinical Outcomes in I.C.U.

Ain Shams University

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Porphyria cutanea tarda.

View clinical trials →

Clinical Trials

View all trials with filters →

No actively recruiting trials found for Porphyria cutanea tarda at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Porphyria cutanea tarda community →

Specialists

13 foundView all specialists →

KM

Karl E Anderson, MD

Specialist

Acute hepatic porphyria Congenital erythropoietic porphyria Disorder of porphyrin and heme metabolism+8 more

PI on 3 active trials

Active trials Directions Travel grants

NM

Nancy D. Perrier, MD

HOUSTON, TX

Specialist

Adenoma of pancreas Embryonal tumor with multilayered rosettes Genetic hyperparathyroidism+3 more

PI on 7 active trials

Active trials Directions Travel grants

AM

Amit Pandya, M.D.

Specialist

Hepatic porphyria Hyperpigmentation of the skin Hypopigmentation of the skin

PI on 3 active trials

Active trials Directions Travel grants

SM

Sean Rudnick, MD

CHARLOTTE, NC

Specialist

Congenital erythropoietic porphyria Disorder of porphyrin and heme metabolism Erythropoietic porphyria+2 more

PI on 1 active trial

Active trials Directions Travel grants

MM

Manisha C Balwani, MD

NEW YORK, NY

Specialist

Acute hepatic porphyria Congenital erythropoietic porphyria Disorder of porphyrin and heme metabolism+7 more

PI on 1 active trial

Active trials Directions Travel grants

BM

Bernard Cribier, MD

Specialist

Neonatal hemochromatosis

PI on 1 active trial

Active trials Directions Travel grants

MM

M. Bagot, MD

Specialist

Neonatal hemochromatosis

PI on 1 active trial

Active trials Directions Travel grants

JM

J.P Lacour, MD

Specialist

Neonatal hemochromatosis

PI on 1 active trial

Active trials Directions Travel grants

OM

O. Chosidow, MD

Specialist

Neonatal hemochromatosis

PI on 1 active trial

Active trials Directions Travel grants

BI

Boehringer Ingelheim

Peoria, Arizona

Specialist

Rare Disease Specialist

Acute graft versus host disease Acute lymphoblastic leukemia Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent+55 more

PI on 123 active trials

Active trials Directions Travel grants

SM

Steven Reynolds, MD

Specialist

Ventilator-induced diaphragmatic dysfunction

PI on 2 active trials

Active trials Directions Travel grants

AM

Ayse Baysal, MD

Specialist

Glomerular disease

PI on 2 active trials

Active trials Directions Travel grants

SK

S K Kabra

Specialist

PI on 1 active trial

Active trials Directions Travel grants

Treatment Centers

8 centers

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Porphyria cutanea tarda.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Porphyria cutanea tardaForum →

No community posts yet. Be the first to share your experience with Porphyria cutanea tarda.

Start the conversation →

Latest news about Porphyria cutanea tarda

Disease timeline:

New recruiting trial: Trial of Acceptance and Mindfulness-based Exposure Therapy (AMBET) and Present Centered Therapy (PCT)

A new clinical trial is recruiting patients for Porphyria cutanea tarda

New recruiting trial: Effects of Barley Green on Visceral Fat Area in the Human Body and Investigation Into the Associated Mechanism of Intestinal Microbiota

A new clinical trial is recruiting patients for Porphyria cutanea tarda

New recruiting trial: Effect of Different Oxygen Concentration on Postoperative Pulmonary Complications After Pulmonary Reexpansion

A new clinical trial is recruiting patients for Porphyria cutanea tarda

New recruiting trial: Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

A new clinical trial is recruiting patients for Porphyria cutanea tarda

New recruiting trial: Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial

A new clinical trial is recruiting patients for Porphyria cutanea tarda

New recruiting trial: Prediction of Mortality and Morbidity After Hip Fracture Using Monocyte Distribution Width (MDW)

A new clinical trial is recruiting patients for Porphyria cutanea tarda

New recruiting trial: KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic Use - Comparing Procalcitonin Kinetics-guided and Absolute Procalcitonin Value-guided Antibiotic Initiation in Reducing Unnecessary Antibiotic Use in Critically Ill Patients

A new clinical trial is recruiting patients for Porphyria cutanea tarda

New recruiting trial: Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

A new clinical trial is recruiting patients for Porphyria cutanea tarda

New recruiting trial: Promoting Optimal Treatment Choices in Neonates With Suspected Early-Onset Sepsis

A new clinical trial is recruiting patients for Porphyria cutanea tarda

New recruiting trial: 3D-PCT Combined With CT-guided Radioactive I-125 Seed Implantation in the Treatment of Head and Neck Tumors

A new clinical trial is recruiting patients for Porphyria cutanea tarda

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Porphyria cutanea tarda

Which specialists treat Porphyria cutanea tarda?

13 specialists and care centers treating Porphyria cutanea tarda are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.